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Abstract Encephalopathy consequent on perinatal hypoxia–
ischemia occurs in 1–3 per 1,000 term births in the UK and
frequently leads to serious and tragic consequences that dev-
astate lives and families, with huge financial burdens for
society. Although the recent introduction of cooling represents
a significant advance, only 40 % survive with normal
neurodevelopmental function. There is thus a significant un-
met need for novel, safe, and effective therapies to optimize
brain protection following brain injury around birth. The
Na+/H+ exchanger (NHE) is a membrane protein present in
many mammalian cell types. It is involved in regulating
intracellular pH and cell volume. NHE1 is the most abundant
isoform in the central nervous system and plays a role in
cerebral damage after hypoxia–ischemia. Excessive NHE ac-
tivation during hypoxia–ischemia leads to intracellular Na+
overload, which subsequently promotes Ca2+ entry via rever-
sal of the Na+/Ca2+ exchanger. Increased cytosolic Ca2+ then
triggers the neurotoxic cascade. Activation of NHE also leads
to rapid normalization of pHi and an alkaline shift in pHi. This
rapid recovery of brain intracellular pH has been termed pH
paradox as, rather than causing cells to recover, this rapid
return to normal and overshoot to alkaline values is deleteri-
ous to cell survival. Brain pHi changes are closely involved in
the control of cell death after injury: an alkalosis enhances
excitability while a mild acidosis has the opposite effect. We
have observed a brain alkalosis in 78 babies with neonatal
encephalopathy serially studied using phosphorus-31 magnet-
ic resonance spectroscopy during the first year after birth
(151 studies throughout the year including 56 studies of 50
infants during the first 2 weeks after birth). An alkaline brain
pHi was associated with severely impaired outcome; the de-
gree of brain alkalosis was related to the severity of brain
injury on MRI and brain lactate concentration; and a persis-
tence of an alkaline brain pHi was associated with cerebral
atrophy on MRI. Experimental animal models of hypoxia–
ischemia show that NHE inhibitors are neuroprotective. Here,
we review the published data on brain pHi in neonatal enceph-
alopathy and the experimental studies of NHE inhibition and
neuroprotection following hypoxia–ischemia.
Keywords Brain pHi . NHE blockade . Neonatal
encephalopathy . Brain alkalosis . Birth asphxyia .
Neuroprotection . Hypoxia–ischemia
Introduction
Encephalopathy consequent on perinatal hypoxia–ischemia
occurs in 1–3 per 1,000 term births in the UK and frequently
leads to serious and tragic consequences that devastate lives
and families, with huge financial burdens for society [1].
Although the recent introduction of cooling represents a sig-
nificant advance, only around 40 % survive with normal
neurodevelopmental function [2]. There is thus a significant
unmet need for novel, safe, and effective therapies to optimize
brain protection following brain injury around birth.
In this review, we discuss both preclinical and clinical
research studies that have led to a better understanding of
the pathophysiology and metabolic pathways following an
acute hypoxic–ischemic perinatal event. Magnetic resonance
spectroscopy (MRS) has been an important tool to understand
the evolution of energy failure and brain intracellular pH (pHi)
after hypoxia–ischemia [3]. Phosphorus-31 (31P) MRS has
demonstrated an alkaline shift in brain pHi [4]; those infants
with worse cerebral injury on magnetic resonance imaging
(MRI) have a more alkaline brain pHi on
31P MRS [5]. It is
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likely that the rapid shift in brain pHi to alkaline values
following hypoxia–ischemia plays an important role in cell
death.
The Na+/H+ exchangers (NHE) are a family of ion mem-
brane transport proteins involved in maintaining a normal pHi
and cell volume in many mammalian cell types, by extruding
protons in exchange for sodium influx into cells in an
electroneutral manner. Excessive activation of NHE is likely
to lead to the alkaline shifts in pHi and increased cell death via
Na+ overload, which promote intracellular Ca2+ entry. Here,
we also review the role of NHE in hypoxia–ischemia, the
evidence of neuroprotection with NHE blockade in animal
models, and the important association of alkaline brain pHi
and seizures.
Acute Hypoxic–Ischemic Perinatal Brain Injury
in the Term Infant
Perinatal hypoxic–ischemic brain injury in the term baby is a
significant problem throughout the world. Hypoxia–ischemia
may occur acutely or chronically and is most commonly asso-
ciated with maternal factors (hypotension, severe hypoxia),
cord factors (prolapse, occlusion), placental factors (insuffi-
ciency and abruption), and uterine factors (rupture). Neonatal
postnatal events such as shock, respiratory, or cardiac arrest can
also lead to hypoxic–ischemic injury. Neonatal encephalopathy
(NE) is the clinical manifestation of the ensuing disordered
brain function and occurs in 1–3 per 1,000 live term births in
the UK and other developed world countries [1]. The enceph-
alopathy typically presents as respiratory difficulties, depres-
sion of tone and reflexes, subnormal level of consciousness,
and often seizures. Serious consequences follow moderate to
severe NE; these include death in 10–15 %, cerebral palsy in
15 %, and other significant cognitive, developmental, and
behavioral problems in 40 % of survivors [6]. The financial
and human costs to the family and society are thus very high.
Following two decades of laboratory studies [7, 8], clinical
trials [2], and recent endorsement from regulatory bodies [9],
therapeutic hypothermia is now the standard clinical care for
moderate to severe NE in the UK and developed world. Meta-
analysis [2, 10] of three large pragmatic trials [2, 11–13] show
that therapeutic hypothermia reduces death or disability at
18 months with a risk ratio of 0.81 (95 % CI 0.71–0.93) and
a number needed to treat of 6–7. Importantly, data are emerg-
ing, which confirm that the favorable outcome of cooled
babies at age 18 months is associated with favorable outcome
at age 7–8 years [14].
However, hypothermia is only partially effective after neo-
natal hypoxia–ischemia, and 40 % of all treated infants still
suffer severe neurodevelopmental disability or death despite
treatment. Additional neuroprotective agents are needed either
to augment hypothermic neuroprotection [15] or to use alone
in settings where hypothermia has not been established as
standard care.
Pattern of Brain Injury on Conventional MRI
Understanding the fundamental mechanisms underlying brain
injury in the newborn brain at term has rapidly advanced in
recent years. Using MRI, the patterns of hypoxic–ischemic
brain injury that have been described in pathology studies in
the past can now be demonstrated in superb detail and reso-
lution in vivo in human neonates [16, 17]. Using MRS, the
timing of the evolution of energy failure and changes in brain
pHi have been fundamental in suggesting new avenues for
neuroprotection.
The two main patterns of injury on MRI have been clearly
described in the 1950s–1970s in a primate model: the injury
pattern associated with acute total asphyxia [18] and with
chronic partial asphyxia [19, 20]. These two main patterns
are described below and in Fig. 1. A normal neonatal MR
image is shown in Fig. 1 (top row). The corresponding 1H
MR spectra acquired from the left thalamus are shown for
each set of MR images. The 1H MRS values from the white
matter are also shown for the watershed predominant pattern
of brain injury.
Predominant basal ganglia–thalamus pattern (BGT) is the
most frequent pattern in “acute asphyxia,” affecting bilaterally
the central grey nuclei (ventrolateral thalami and posterior
putamina) and perirolandic cortex (Fig. 1 middle row). The
hippocampus and brainstem can also be involved. This pattern
of injury is most often seen following an acute sentinel event,
e.g., uterine rupture, placental abruption, or prolapsed cord
[21]. The basal ganglia and thalami are susceptible to acute
perinatal hypoxic–ischemic injury due to their high metabolic
rate and increased concentration of NMDA receptors [22].
Survivors face a range of functional impairments, which in-
clude cerebral palsy, feeding problems, speech and language
problems, visual and hearing impairment, later seizures, be-
havioral difficulties, and cognitive impairment. Cerebral palsy
affects three quarters of infants with NE with BGT lesions,
and the severity of the BGT lesions is the best predictor of
motor problems. A normal signal intensity of the posterior
limb of the internal capsule within the neonatal period follow-
ing neonatal encephalopathy is a good predictor of the ability
to walk at 2 years [23].
Watershed predominant pattern of injury typically follows
“prolonged partial asphyxia.” The areas involved are the vascu-
lar watershed zones (anterior–middle cerebral artery and poste-
rior–middle cerebral artery), affecting white matter and in more
severely affected infants the overlying cortex (Fig. 1, bottom
row). The lesions can be uni- or bilateral, posterior and/or
anterior. Conventional MRI can detect the loss of the cortical
ribbon [24, 25]. These lesions may become cystic, atrophy, or
develop gliosis [26]. Common associated etiological factors are
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hypotension, infection, and hypoglycemia [27]. Infants with a
watershed pattern of injury have predominantly cognitive im-
pairments often without functional motor deficits. Cognitive
deficits include memory impairments, visual–motor or visual–
perceptive dysfunction, or increased hyperactivity, sometimes in
the absence of functional motor problems [28–32].
Fig. 1 Patterns of brain injury on MRI. Top row (3 Tesla): a axial T1-
weighted (w) MPRAGE and bT-2 w 2D 3 mm 3 T MRI of a term infant
with normal intracranial appearances on day 5 after birth. This infant
presented with stage 1 (mild) neonatal encephalopathy. A normal signal
intensity is seen from the posterior limb of the internal capsule on aand b.
A thalamic proton (1H) magnetic resonance (MR) spectrum TE 288 ms
from the same infant is shown in c. The lactate peak at 1.3 ppm is just
visible. Middle row (3 Tesla): a axial T1-w MPRAGE and b axial T2-w
2D 3 mm of an infant with a predominant BGT pattern of brain injury
(involvement of basal ganglia, thalami, and perirolandic cortices). A
thalamic 1H MR spectrum TE 288 ms from the same infant is shown
in c. A high thalamic Lac/NAA ratio of 5.57 is observed. Bottom row
(1.5 Tesla): a axial T1-w; b axial T2-w 2D 3 mm of an infant with
neonatal encephalopathy with a predominant watershed injury pattern.
Areas of cerebral cortical infarction affecting the insular cortices, frontal,
and temporal occipital lobes in anterior and posterior arterial watershed
territory is seen. A thalamic 1H MR spectrum TE 288 ms from the same
infant is shown in c. The Lac/NAA is normal in the thalamus. The white
matter spectrum (not shown) has a raised Lac/Cr peak area ratio
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Cerebral Energy Metabolism Following Perinatal Hypoxia–
Ischemia
MRS has been used to study brain energy metabolism nonin-
vasively; over the last 30 years phosphorus-31 (31P) and
proton (1H) MRS have provided unique information on cere-
bral energy metabolism during the evolution of brain injury
following hypoxia–ischemia in the newborn infant [33], neo-
natal rat [34], and the newborn piglet [3, 35] (Fig 2). In human
infants, shortly after intrapartum hypoxia–ischemia 31P MRS
often reveals normal cerebral energetics [36]. However, in
infants with adverse outcome, despite adequate oxygenation
and circulation, phosphocreatine (PCr) and nucleotide triphos-
phate (NTP, mainly ATP) decline, and Pi increases, in the first
days of life [33, 36–38]. Brain pHi has been observed to
become alkaline during this phase [4, 5] (see next section).
These metabolic changes were termed “secondary energy
failure” (SEF) on the basis that they followed impaired
intrapartum cerebral energy generation (resulting in transient-
ly reduced PCr and NTP and increased Pi), which resolved
following resuscitation [3] (Fig. 3). It was assumed that SEF
was consequential to a pathological mechanism initiated by
intrapartum hypoxia–ischemia or/and reperfusion/
reoxygenation. 1HMRS provides complementary information
to 31P MRS (in particular cerebral lactate, a marker of anaer-
obic metabolism and N-acetyl-aspartate (NAA), an abundant
amino acid found mostly in neurons in the central nervous
system (CNS) [39]). Because of the greater sensitivity of the
1H nucleus, data can be obtained from smaller regions of the
brain. Cerebral lactate rises and NAA falls during transient
hypoxia–ischemia; these metabolites return almost to baseline
levels after successful resuscitation, only to be followed by a
secondary increase in lactate and slower reduction in NAA in
the hours that follow. These 1HMRS changes occur in parallel
to the energy disruption (reduction in PCr/EPP and NTP/EPP)
seen on 31P MRS. A recent meta-analysis of the prognostic
accuracy ofMRmethods demonstrated that thalamic 1HMRS
Lac/NAA peak area ratio acquired between days 5 and 14
after birth is a highly sensitive and specific biomarker of long-
term neurodevelopmental outcome in infants with neonatal
encephalopathy [40].
Brain pHi Changes in Babies with Neonatal Encephalopathy
31P MRS is the only noninvasive way to measure pHi apart
from positron emission tomography, which requires injection of
radioactive ligands and is not feasible in babies. Using 31P
MRS, brain pHi can be measured using the chemical shift
difference of Pi from PCr [41], or phosphoethanolamine from
PCr [42, 43] or ATP from PCr [44]. The pHi value calculated
from the chemical shift difference of Pi form PCr is thought to
reflect the pHi in dead or injured cells, whereas that derived
from other metabolites may reflect different cell populations. A
summary of the studies of brain pHi using
31P MRS performed
in normal neonates and infants is shown in Table 1.
Brain pH homeostasis in the cytosol and other cellular
compartments is maintained by a dynamic, finely tuned bal-
ance between proton-extruding and proton-importing process-
es [45]. Under physiologic conditions, the extracellular pH is
∼7.4; however, the cytosolic pH is more acid (∼7.2). Other
organelles possess their own specific pH (Fig. 4). Almost all
proteins depend on pH to maintain their structure and func-
tion; pH plays an important part in many metabolic functions
and the charge of biological surfaces affects many cellular
reactions. There is a tendency for the cytosol to accumulate
acid (from metabolic reactions—ATP production in the cyto-
plasm by glycolysis and in mitochondria by oxidative phos-
phorylation) (Fig. 5). Protons are actively extruded from the
cytosol by proton pumping ATPases, coupling to other sub-
strates through exchangers; the main transporter that protects
cells against acidification is the Na+/H+ exchanger (see “Brain
pHi and Seizures”).
In 2002, we studied the chemical shift difference of Pi in
whole-brain 31P MRS in relation to outcome in babies with
neonatal encephalopathy [5]. In 78 babies with neonatal
Fig. 2 Representative 31P MRS spectra from a a normal baby and b a
baby with severe neonatal encephalopathy. Seven main peaks can be
assigned in a cerebral 31P MR spectrum: phosphomonoesters (PME),
inorganic phosphate (Pi), phosphocreatine (PCr), phosphodiesters
(PDE), and the three phosphate groups (α, β, and γ) in nucleotide
triphosphate (NTP). The chemical shift difference between PCr and Pi
forms the basis of intracellular pH measurement in the in vivo brain
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encephalopathy studied serially during the first year after birth
(151 studies throughout the year including 56 studies of 50
infants during the first 2 weeks after birth), we demonstrated
that: (1) alkaline brain pHi was associated with severely
impaired outcome in babies; (2) the degree of brain alkalosis
was related to the severity of brain injury on MRI and brain
lactate concentration (Fig. 6); and (3) brain alkalosis persisted
for several weeks in babies with a severely impaired outcome
and persistence was associated with cerebral atrophy on MRI.
A brain pHi of 7.15 and above measured in the first 2 weeks
after birth had a sensitivity of 71 % and specificity of 92 % for
predicting adverse outcome. Published studies that have mea-
sured brain pHi using
31P MRS in infants with birth asphyxia
are listed in Table 2.
In vivo data suggest that the return of pHi to normal or
alkaline values may be deleterious to cells that have under-
gone hypoxia–ischemia. This rebound alkalosis has been
termed pH paradox and has been described in several cell
types [46–48]. Possible mechanisms leading to pH-dependent
injury include activation of phospholipases and proteases,
which have an alkaline pKa, onset of the mitochondrial per-
meability transition pore, leading to uncoupling of oxidative
phosphorylation and aggravation of ATP depletion [49], and
an exacerbation of excitotoxic neuronal injury due to an
increased NMDA activation at alkaline pHi [50, 51]. An
understanding of one of the main transporter groups leading
to brain alkalosis after hypoxia–ischemia (the NHEs) is there-
fore important for future neuroprotection strategies.
Na+/H+ Exchangers
The NHEs are a family of ion integrate membrane transport
proteins involved in maintaining pHi and cell volume in many
mammalian cell types [52, 53], by extruding protons from,
and taking up sodium ions into cells in an electroneutral
manner (1:1 stoichiometry) (Fig. 5).
To date at least ten NHE isoforms (NHE1 to NHE10) have
been identified in mammals [54]. NHE10 was recently de-
scribed as an osteoclast-specific member of NHE family,
regulating osteoclasts differentiation and survival [55].
NHE1–5 are expressed on the plasma membranes in various
types. NHE6–9 reside on intracellular organellar membranes
of the endosomal-trans Golgi network [56, 57]. NHE isoforms
have similar membrane topologies, with an N-terminal mem-
brane domain consisting of 12 predicted transmembrane seg-
ments and a more divergent C-terminal cytoplasmic domain
[45, 57]. The NHE1 isoform has been studied closely and is
present at the cell surface of most cells, especially plasma
membranes. It is the most abundant isoform in the CNS [58,
59]. NHE1 plays a crucial role in protecting cells from internal
acidification, acting together with bicarbonate-transporting
systems and restoring cell volume to steady-state levels [60].
Intracellular acidosis is the major stimulus that regulates
NHE1 activity. As the H+ concentration of the cytosol rises, a
rapid increase in the activity of the transporter occurs. Near-
maximal velocity is achieved in approximately one pH unit
(Hill coefficient >1), thereby minimizing exposure of the
cytoplasm to excess acidification [61, 62].
In addition to responding to intracellular acidification, vari-
ous signals can alter the NHE1 internal pH sensitivity, such as
hormones, mitogens, and physical stimuli (e.g., mechanical
stretch and hyperosmolarity), modulating its state of phosphor-
ylation [45, 53, 63–67]. The exchange activity is more active at
alkaline pH values due to a shift of the set point by phosphor-
ylation of the residues. It is also regulated at the transcriptional
level, supporting the control at mRNA levels and at protein
production level [68, 69]. An alkaline cytoplasmic pH (pHc) is
thought to provide a permissive environment for the progres-
sion of diverse cellular processes, including changes in cell
Fig. 3 Schematic diagram illustrating the biphasic pattern of energy
failure associated with a transient hypoxia–ischemic insult visualized
using 31P MRS in the UCL piglet model. Nucleotide triphosphate
(NTP)/exchangeable phosphate pool (EPP=Pi+PCr+NTP) is shown on
the y-axis. The change in NTP/EPP during transient hypoxia–ischemia
(HI), resuscitation, the latent phase (period between the recovery from
acute HI and the evolution of secondary energy failure (SEF)), and SEF
itself are shown. During the acute energy depletion, some cells undergo
primary cell death, the magnitude of which will depend on the severity
and duration of HI. Following perfusion, the initial hypoxia-induced
cytotoxic edema and accumulation of excitatory amino acids typically
resolve over 30–60 min with apparent recovery of cerebral oxidative
metabolism (latent phase). It is thought that the neurotoxic cascade is
largely inhibited during the latent phase and that this period provides a
“therapeutic window” for therapies such as hypothermia and other agents.
Cerebral oxidative metabolism may then secondarily deteriorate 6–15 h
later (as SEF). This phase is marked by the onset of seizures, secondary
cytotoxic edema, accumulation of cytokines, and mitochondrial failure
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shape [70], adhesion [71], migration [72, 73], chemotaxis [74,
75], and proliferation [76–78].
Effect of Hypoxia–Ischemia on NHE
Reductions in blood flow with ischemia and reduction in
oxygen supply with hypoxia decrease the supply of oxygen
required to maintain tissue ATP levels, especially in excitable
organs such as the heart and brain that have a high demand for
energy. As ATP stores are depleted, lactate, pyruvate, and
protons accumulate owing to anaerobic metabolism of glyco-
gen stores. The accompanying cytoplasmic acidification
causes hyperactivation of plasma membrane NHE1 and the
consequent accumulation of intracellular Na+. The Na+ over-
load reverses the mode of operation of Na+/Ca2+ exchange,
driving excess Ca2+ into the cell. The resulting elevation in
intracellular Ca2+ concentration, and subsequent activation of
proteases, phospholipases, and formation of oxygen- and
nitrogen-free radicals, precipitates a cascade of deleterious
effects, including altered membrane excitability and contrac-
tility, generation of toxic free radicals, cellular hypertrophy,
apoptosis, and necrosis—events that result in cell death [79,
80]. Activation of NHE also leads to the rapid normalization
of pHi during reperfusion after hypoxia ischemia [45, 54, 81,
82].
Removal of external Na+ or reducing the external pH
attenuates the postanoxia alkalization [83]. When ATP levels
fall to 35 % of control in isolated CA1 neurons during chem-
ical anoxia, NHE activity is reduced by 44 %. Activation of
NHE function, Na+ pump function and the Na+ driving for
NHE are all dependent upon ATP energy levels, ATP being
required for phosphorylation of the protein.
NH Exchanger Blockade and Neuroprotection in Neonatal
Models
Although the NHE activation is essential for the restoration of
physiological pHi, hyperactivation of NHE1 in neurons, in
response to the metabolic acidification associated with an
ischemic–hypoxic insult [46, 84–87], disrupts the intracellular
ion balance, causing intracellular Na+ and Ca2+ overload [88],
which eventually leads to cell death. Experimental in vitro and
in vivo studies have demonstrated neuroprotection with NHE
inhibitors; these are summarized in Table 3.
There are two major classes of pharmacological NHE
inhibitors. One class includes amiloride and its derivatives
by double substitution of the nitrogen of the 5-amino group:
dimethylamiloride (DMA), N-(N-ethyl-N-isopropyl)-
amiloride (EIPA), N-methyl-isobutyl-amiloride (MIA), and
5-(N,N-hexamethylene)-amiloride. They are nonselective in-
hibitors of the NHE system in various cell types, and EIPA is
highly potent. Another class of inhibitors includes the deriv-
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(cariporide mesilate or 4-isopropyl-3-methylsulfonylbenzoyl-
guanidine methanesulfonate), eniporide, and BIIB-513, which
selectively inhibited NHE1. The replacement of the pyrazine
ring of amiloride by a pyridine ring or by a phenyl increased
the potency and the NHE selectivity. In the last two decades,
several bicyclic guanidines were prepared: zoniporide, MS-
31038, SM-20220, SM-20550, SMP-300, KBR9032, BMS-
284640, T-162559, TY-12533, S-3226, or SL-591227 [52]. Of
these, HOE 642 is extremely potent, being 105 times more
specific for NHE1 vs. NHE3 [78], and zoniporide is very
potent too and 150-fold selective for NHE1 vs. the other











ExtracellularFig. 4 A schematic diagram
showing the pH of the main
cellular compartments in a typical
mammalian cell (fromCasey et al.
[45]) The mitochondrial pH
represents that in the inner
mitochondrial membrane
Fig. 5 Ion transporters that regulate cytoplasmatic pHi. There is a ten-
dency to acidification of the cytoplasm due to the activity of the anaerobic
metabolism producing lactate from glucose and aerobic metabolism
(oxidative phosphorylation in mitochondria that produce CO2). The main
transporters regulating cytosolic pH are the plasma membrane Na+/H+
exchangers (NHEs) (see (1) on the diagram) and the Na+/HCO3
−
cotransporters (NBCs) (2). The plasma membrane Cl−/HCO3
− or anion
exchangers (AE) (3) counterbalance these mechanisms by acidifying the
cell, and plasma membrane Ca2+-ATPases (4) also acidify the cytosol by
exchanging cytosolic Ca2+ for extracellular H+ when intracellular Ca2+ is
elevated. Importantly in the brain after hypoxia–ischemia, the monocar-
boxylate-H+ co-transporters (MCTs) will alkalinize the cell (5). The Na+/
K+-ATPase pumps (6) establish an inward electrochemical Na+ gradient.
Adapted from (from Casey et al. [45]). CA carbonic anhydrase, LDH
lactate dehydrogenase, pHi intracellular or cytosolic pH, pHo extracellular
or outside pH
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inhibitors. Harmaline is a nonamiloride NHE5 inhibitor. The
inhibitory potency of NHE inhibitors towards the different
NHE isoforms is described in detail in a review by Masereel
et al., [52].
During in vitro cerebral ischemia, NHE inhibitors (DMA,
harmaline [46], SM-20220 [88], amiloride [89], and HOE-642
[85, 87, 90]) had a protective effect, in terms of delayed pHi
normalization both in neuronal cells and in astrocytes [46,
89–92], inhibition of microglia [90], and less intracellular
calcium accumulation [87, 88]. This anoxia-induced
alkalization was also ameliorated in NHE1−/− CA1 neurons.
In parallel, cell death was reduced in wild-type neurons treated
with HOE 642 or in NHE1−/− neurons in cultured mouse
cortical neurons undergoing 3 h oxygen–glucose depriva-
tion (OGD) and 21 h reoxygenation (from ∼70 % to
40–50 %) [87].
Vornov et al. [46], described that pHi decreased by 0.2 pH
units, but then recovered when inhibition was removed in rat
cortical neuronal cultures undergoing metabolic inhibition for
20 min. NHE1 inhibitors, dimethylamiloride or harmaline,
significantly reduced the postinhibition pHi recovery, showing
less brain injury in these compared to those with a fast pHi
normalization.
As mentioned above, NHE1 activity also affects cellular
Na+ levels. A small but significant (∼2-fold) increase in neu-
ronal intracellular concentration of Na+ ([Na+]i) results after
2 h OGD, reaching to ∼7-fold increase during 1 h reoxygen-
ation. HOE 642 attenuated the rise in [Na+]i following OGD.
NHE1−/− neurons did not exhibit significant increase in
[Na+]i. This supports that NHE1 activity is elevated upon
reoxygenation [83, 86]. Three hours of OGD and 21 h reox-
ygenation lead to cell death in ∼70 % of the NHE1+/+ neu-
rons. However, cell death is significantly reduced in wild-type
neurons treated with HOE 642 or in NHE1−/− neurons [87].
In vivo studies mainly in rodents have found that NHE1
inhibitors reduce brain injury in hypoxia–ischemia models
[93] and decrease infarct size in a focal ischemia model [87].
In NHE1 heterozygous mice, there was a significant decrease
in infarct size of around 30 % compared with normal NHE+/+
mice following middle cerebral artery occlusion (MCAO)
[87], similar to those NHE+/+ mice treated with HOE 642.
It implies that the disruption of Na+ and Ca2+ homeostasis
contributes to ischemic neuronal damage. These studies firmly
demonstrate the dominant role of NHE1 among other NHE
isoforms in cerebral ischemic brain damage.
Other studies show neuroprotection in ischemic models.
SM-20220 (N-(aminoiminomethyl)-1-methyl-1H-indole-
2-carboxamide methanesulfonate), a highly selective NHE1
inhibitor, given intravenously 1 h after MCAO significantly
reduced the extent of cerebral edema and Na+ content after 2 h
ischemia and 4 h reperfusion and infarct volume after 22 h
reperfusion [94]. SM-20220 decreased infarct size in both
transient and permanent MCAO models. The reduction of
infarct size improved when the treatment is delayed for 5,
30, or 60 min after the onset of ischemia [94]. SM-20220 led
to ∼50 % decrease in infarct size at 72 h reperfusion. Other
groups have shown similar reductions in infarct volume and
edema with other NHE blockers [95–97].
Some NHE blockers, specifically SM-20220 [98] andMIA
[93], have been found to reduce the number of neutrophils in
the ischemic hemisphere. SM-20220 attenuates leukocyte ad-
hesion and migration in the mesenteric artery [99] and im-
proves endothelial dysfunction [100]. NHE1 blockers (EIPA
and HOE 642) [84, 90, 101, 102] reduced microglial activa-
tion posthypoxia ischemia and hence the microglial phagocy-
tosis and astrocytosis in CA1 region. Cengiz et al. [102] found
that HOE 642 given either prehypoxia–ischemia or starting
10 min after the insult reduced neurodegeneration in the acute
stage in hippocampus, striatum, and ipsitaleral thalamus, and
improved the striatum-dependent motor and spatial learning
skills at 8 weeks.
NHE1 inhibitors are neuroprotective in astrocytes in a
similar way to neurons. The intracellular Na+ overload is
substantially mediated through activation of the ERK1/2 path-
ways [92]. In a more severe model of in vitro ischemia,
cultured astrocytes were superfused with a solution, which
Fig. 6 Association of the severity of brain injury in conventional MRI
andmean brain pHi within the first 2 weeks of age in 50 infants with mild,
moderate, and severe neonatal encephalopathy. Mean (SD) brain pHi at
<2 weeks of age in infants with neonatal encephalopathy classified
according to the brain MRI pattern (data from Robertson et al. [5]). There
are significant differences between the brain pHi in the group with a
normal brain MRI and the brain pHi in the group with a severely
abnormal MRI
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mimics the ionic composition of the ischemic extracellular
space (a hypoxic, acidic, ion shifted ringers (HAIR) solutions
at 37 °C) [103, 104]. Exposure to HAIR caused a rapid decline
in astrocyte pHi. This is consistent with the finding that NHE1
activity is inhibited by low extracellular pH (pHe) [105].
When exposed to normal buffer again, astrocytes rapidly
alkalized and a significant rebound of pHi over the baseline
took place [104]. Bondarenko et al. [104] have reported that
HAIR and reoxygenation leads to ∼40 % cell death in astro-
cytes, which is significantly reduced in the presence of NHE
blockers such as EIPA or HOE 694 during HAIR and reoxy-
genation, or during reoxygenation alone.
NHE inhibitors have also been shown to preserve neuro-
logical function after ischemic injury. In a model of ischemia
and hypothermia in piglets, Castella et al. [106] observe a
rapid neurological recovery in subjects receiving HOE 642
just at the onset of cooling. Several studies [84, 107] demon-
strate that EIPA not only protects gerbil hippocampal neurons
from ischemic injury but also reduces the magnitude of the
ischemia-induced locomotor hyperactivity at both 24 h and
6 days after reperfusion. Ischemic injury to the gerbil forebrain
produces an increase in locomotor activity, which is related to
the degree of pyramidal neuronal damage in the CA1 region
of the hippocampus [84, 108]. In another Mongolian gerbil
model, the recovery time of consciousness significantly im-
proved (lower neurological scores at 2 h postreperfusion)
following a 30 min transient global cerebral ischemia in those
treated with SM-20220, compared to the vehicle group [109].
This improvement in neurological deficit persisted until 24 h
postreperfusion.
In summary, NHE inhibitors (or genetically modified NHE1
−/−) are neuroprotective in animal models. They reduce the
alkalinization of the cell (inhibition of phospholipases and ki-
nases [107, 110] and delayed secondary energy failure [89]),
and decrease the calcium and sodium intracellular overload,
reducing cell edema and cell damage. They suppress microglial
activation, especially in hippocampal regions (pyramidal neu-
rons of the CA1 area in rodents) [84] and in striatum and
ipsilateral thalamus in a focal ischemia model [102]. Improved
functional outcome also follows NHE inhibition [102].
NHE Inhibition Following Transient Hypoxia–Ischemia
in the Piglet Model of Perinatal Asphyxia
Robertson et al. [111] used the piglet model of perinatal
asphyxia to study the effect of NHE1 inhibition with MIA
given 10 min after the end of hypoxia–ischemia and eight
hourly thereafter. MIA improved cerebral energy metabolism
in the thalamic area in the 48 h after hypoxia–ischemia on
MRS biomarkers and reduced cell death and microglial acti-
vation in some brain areas. The use of clinically relevant MRS
biomarkers and reduced cell death in a large animal model of
perinatal asphyxia is an important step towards the clinical
translation of NHE inhibitors. It is important to assess whether
NHE blockade would augment hypothermic neuroprotection
in this devastating disease.
Brain pHi and Seizures
Relation Between Brain pHi and Seizures
Neonatal seizures are the most common manifestation of a
neurological disorder in the newborn period. Neonatal en-
cephalopathy is the most frequent cause of seizures at term.
In some studies, the duration of electrographic seizures in
newborn babies is associated with worse MRI appearances
[112] and poor neurodevelopmental outcome [113]. Newborn
babies with neonatal encephalopathy as a cause of seizures
tend to have a higher seizure burden than those with a stroke
[113]. Increased morbidity and mortality, brain injury, and
poor neurodevelopmental outcome have been associated with
a higher seizure burden [113–120]. Therefore, addressing
neonatal seizures is a priority, but current drugs are largely
ineffective and are not free of serious side effects on the
neonatal brain [121–123].
Therapeutic hypothermia not only improves outcomes of
babies with neonatal encephalopathy by reducing the rate of
death and disability at 18 months of age, but it also appears to
reduce seizure burden [124]. Cooling appears either to act
directly to reduce seizure burden or to augment the action of
conventional anticonvulsants. Xenon gas, which is currently
being used in clinical phase II trials to augment hypothermic
neuroprotection in babies, appears to reduce seizure burden
when administered with cooling [125]. The data are consistent
with those from preclinical models [124].
There is however still an unresolved controversy whether
seizures worsen outcome by themselves or whether they are
associated to those with a more severe degree of encephalop-
athy, hence the higher mortality and morbidity [126, 127]. The
molecular and cellular mechanisms underlying birth-asphyxia
seizures are unknown, but understanding the seizure-
triggering mechanisms plays a key role in the design of novel
therapeutic strategies.
A profound acidosis (blood pH 7.00 or lower) at the time of
birth is an essential criterion in the diagnosis of perinatal
asphyxia [128, 129]. However, postasphyxia seizures do not
coincide with the maximal blood acidosis but are typically
first observed during the recovery period after a delay that
usually ranges in human babies from 2 to 16 h [130]. Awide
range of observations have shown that changes in extra- and
intracellular pH exert a strong modulatory effect on brain
excitability under normal and pathophysiological conditions,
whereby an alkalosis enhances excitability while an acidosis
has an opposite effect [131–138]. The immature brain appears
to be particularly sensitive to changes in pHi. Recent
92 Transl. Stroke Res. (2014) 5:79–98
experiments have shown that changes of 0.05 pH units on
neonatal hippocampal slices have a profound effect on endog-
enous network activity [137].
In a rat pup model of neonatal asphyxia, brain alkalosis
after recovery from asphyxia played a key role in the trigger-
ing of seizures [138]. Brain pH was measured with
intracortical ion sensitive microelectrodes, and EEG was re-
corded from parietal cortex in freely moving rat pups with
simultaneous video recording [138]. There was a robust cor-
relation between postasphyxic brain pH changes and seizure
burden; that is, the more alkaline the brain pH after asphyxia,
the higher the seizure burden. The alkaline brain pH overshoot
after asphyxia reached values of up to 0.40 pH units above
normal brain pH; these are similar finding to previous studies
in rats [93], piglet [3, 111], and human newborn [4, 5]. Some
pups received MIA (the NHE inhibitor) intraperitoneally
30 min before asphyxia; in those rat pups pretreated with
MIA, seizure burden was reduced. These data add weight to
the evidence that acidosis suppresses neuronal excitability,
whereas alkalosis does the opposite [133, 139–141]. Taking
this further, there is accumulating evidence that brain pHi
plays a key role in modulating neuronal survival after injury
[131, 142, 143].
In another study in neonatal rat pups by the same group, a
rise in brain pH was accompanied by seizure activity follow-
ing injection of sodium bicarbonate [144]. The authors sug-
gested that a “graded restoration of normacapnia” should be
recommended for resuscitation of neonatal encephalopathy as
this may reduce seizures and improve outcome [144].
The same group explored mechanisms of postasphyxia
brain alkalosis [145] in the rat pup exposed to one hour of
asphyxia (simultaneous hypoxia and hypercapnia). They ob-
served that the postasphyxia brain alkalosis was generated in
the absence of a rise of blood pH. The increase in both
extracellular and intracellular pH recorded in the brain implied
an enhanced net loss of acid equivalents from brain tissue
across the BBB. BBB disruption itself was excluded by the
absence of increased sodium fluorescein extravasation into the
brain and by electrophysiological characteristics of the BBB
[145]. The net efflux of acid equivalents from the brain across
the BBBwas abolished byMIA, suppressing the postasphyxia
rebound alkalosis of the brain extracellular pH without having
any significant effect on the weight of the pups. Remarkably,
MIA also abolished postasphyxia seizures (reduced seizure
burden by 88%) when applied preinsult in rat pups [138, 145]
and ameliorated brain injury when applied before hypoxia–
ischemia in neonatal mice [93]. These findings support the
conclusion that activation of NHE in the BBB leads to brain
alkalosis and consequent seizures.
Therapeutic hypothermia is now standard care for infants
in the developed world with moderate to severe neonatal
encephalopathy [146]. It is unknown if NHE inhibition com-
bined with therapeutic hypothermia might augment
hypothermic neuroprotection after perinatal asphyxia. Some
in vitro studies suggest that moderate hypothermia (reducing
temperature from 37 to 20 °C) itself increases NHE activity
[147, 148], while others suggest that hypothermia produces a
partial inhibition of NHE activity [149]. The combined effects
of an NHE inhibitor with hypothermia could significantly
augment hypothermic neuroprotection especially as they act
on separate pathways. Importantly, studies suggest that the
potency of NHE inhibition under hypothermic conditions is
not influenced by a change in temperature [149] and NHE
inhibition was beneficial in a perfused heart model even after
hypothermic ischemia [150]. Preclinical large animal studies
of combined therapy with cooling are high priority.
Summary
Perinatal hypoxic–ischemic brain injury in term babies is still
a significant problem throughout the world. Therapeutic hy-
pothermia has improved outcome, especially of those with a
moderate insult. Unfortunately, around 40 % of infants treated
with therapeutic hypothermia still have adverse outcomes.
Experimental data suggest that the addition of another agent
to cooling may enhance overall protection either additively or
synergistically. Experimental models have demonstrated the
central role of NHE in maintaining brain pHi and ion homeo-
stasis, and in microglial activation in some areas of the brain.
NHE inhibitors are a promising neuroprotective agent in
animal models, improving brain energy metabolism in
in vivo MRS, reducing cell death, seizure burden, and brain
injury with improvement of functional outcome. Preclinical
studies are urgently needed to assess possible augmentation of
hypothermic neuroprotection with NHE inhibition.
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